Fwd: Mayors welcome tagging crackdown

---------- Forwarded message ----------
From: Search for lung cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:07 PM
Subject: Mayors welcome tagging crackdown
To: mesothelioma77@gmail.com

Auckland mayors have welcomed a proposed crackdown on tagging, but the National Party says government action has come too late.

Fri, 15 Feb 2008 02:38:46 GMT

---

Source: http://nz.news.yahoo.com/080215/3/409q.html
--
 ~
Powered by RssFwd, a service of Blue Sky Factory, Inc

Fwd: External hypofractionated whole-breast radiotherapy: now where does accelerated partial breast irradiation stand?

---------- Forwarded message ----------
From: HubMed - breast cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:07 PM
Subject: External hypofractionated whole-breast radiotherapy: now where does accelerated partial breast irradiation stand?
To: mesothelioma77@gmail.com


[1]J Cancer Res Ther. 2007 Oct-Dec; 3(4): 231-5
Munshi A

Breast-conserving therapy (BCT) has emerged as a viable option for suitable breast cancer patients who are desirous of preserving the breast. The major advantage of BCT is the good cosmetic outcome with disease-free and overall survival similar to mastectomy. In this article, I have compared two emerging modalities for treating a preserved breast with radiotherapy. These two techniques in breast cancer - accelerated partial breast irradiation (APBI) and hypofractionated whole breast external beam radiotherapy - have their respective merits and drawbacks, and this article attempts to dissect the issue.



___
Source: http://www.hubmed.org/display.cgi?uids=18270399
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Robotic tumor-specific mesorectal excison of rectal cancer: short-term outcome of a pilot randomized trial.

---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: Robotic tumor-specific mesorectal excison of rectal cancer: short-term outcome of a pilot randomized trial.
To: mesothelioma77@gmail.com


[1]Surg Endosc. 2008 Feb 13;
Baik SH, Ko YT, Kang CM, Lee WJ, Kim NK, Sohn SK, Chi HS, Cho CH

BACKGROUND: Laparoscopic colorectal resection has become popular. The recently developed da Vinci Surgical System promises to facilitate endoscopic surgery and overcome its disadvantages. This study therefore aimed to compare the short-term results between robotic tumor-specific mesorectal excision (R-TSME) using the da Vinci Surgical System and conventional laparoscopic tumor-specific mesorectal excision (L-TSME) in rectal cancer patients. METHODS: Between April 2006 and February 2007, 36 patients were randomly assigned to receive R-TSME or L-TSME. During the study, 18 patients underwent robotic low anterior resection using the da Vinci Surgical System, and 18 patients had conventional laparoscopic low anterior resection. Patient characteristics, perioperative clinical results, complications, and pathologic details were compared between the two groups. RESULTS: The patient characteristics were not significantly different between the two groups. The mean operating time, hemoglobin change, and conversion rate were not significantly different between the groups. Complications were treated conservatively and did not require surgical intervention in the R-TSME group. The average length of stay was 6.9 +/- 1.3 days in the R-TSME group and 8.7 +/- 1.3 days in the L-TSME group (p

___
Source: http://www.hubmed.org/display.cgi?uids=18270772
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Large Colonic Lipoma Mimicking Colon Cancer and Causing Colonic Intussusception.

---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: Large Colonic Lipoma Mimicking Colon Cancer and Causing Colonic Intussusception.
To: mesothelioma77@gmail.com


[1]Dig Dis Sci. 2008 Feb 14;
Martin P, Sklow B, Adler DG





___
Source: http://www.hubmed.org/display.cgi?uids=18270829
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: a decision analysis.

---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Thu, Feb 14, 2008 at 11:06 PM
Subject: Cost-effectiveness of laparoscopy versus laparotomy for initial surgical evaluation and treatment of potentially resectable hepatic colorectal metastases: a decision analysis.
To: mesothelioma77@gmail.com


[1]J Surg Oncol. 2008 Feb 12;
Karuna ST, Thirlby R, Biehl T, Veenstra D

BACKGROUND AND OBJECTIVES: Approximately 10-40% of colorectal cancer patients with potentially resectable hepatic metastases are incorrectly deemed resectable on standard pre-operative evaluation, including contrast-enhanced CT. Laparoscopy can identify unresectability in a majority of patients at highest risk of being incorrectly deemed resectable, sparing them an unnecessary laparotomy. However, laparoscopy requires an added investment by surgeons, patients, and payers. This analysis seeks to ascertain whether that investment is cost-effective. METHODS: A decision tree model was developed to evaluate the societal cost-effectiveness of laparoscopy versus laparotomy in colorectal cancer patients with hepatic metastases deemed resectable on standard pre-operative evaluation. This comparison involved the cost, the effectiveness, and the incremental cost-effectiveness (the cost in dollars for each quality-adjusted life-year saved) of each option. Sensitivity analysis was performed to evaluate the model's validity under a variety of assumptions. RESULTS: The cost-effectiveness of performing laparoscopy prior to laparotomy for resection of colorectal hepatic metastases depends primarily upon the probability of resectability determined at laparoscopy, and on the sensitivity of diagnostic laparoscopy. CONCLUSION: Laparoscopy for initial evaluation of resectability of hepatic metastases from colorectal cancer is most likely to benefit patients and save costs when performed after pre-operative risk stratification in patients at high risk of radiographically occult unresectable disease. J. Surg. Oncol. (c) 2008 Wiley-Liss, Inc.



___
Source: http://www.hubmed.org/display.cgi?uids=18270972
--
 ~
Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc